We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+10.45%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.29B
AUM Growth
-$264M
Cap. Flow
-$511M
Cap. Flow %
-15.51%
Top 10 Hldgs %
40.48%
Holding
97
New
23
Increased
21
Reduced
21
Closed
30

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$102M
2
AMZN icon
Amazon
AMZN
+$92.7M
3
SCHW
Charles Schwab
SCHW
+$88M
4
BABA icon
Alibaba
BABA
+$82.5M
5
SYF icon
Synchrony
SYF
+$61.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$166M
2
UNH icon
UnitedHealth
UNH
+$151M
3
HCA icon
HCA Healthcare
HCA
+$137M
4
GILD icon
Gilead Sciences
GILD
+$110M
5
LLY icon
Eli Lilly
LLY
+$92.6M

Sector Composition

Rank Sector Weight
1 Healthcare 48.02%
2 Technology 9.28%
3 Industrials 8.23%
4 Financials 7.66%
5 Communication Services 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
76
Mastercard
MA
$498B
– –
-500,093
Closed -$45.1M
MCK icon
77
CALL
McKesson
MCK
$104B
– –
-343,100
Closed -$26K
MRK icon
78
PUT
Merck
MRK
$322B
– –
-1,363,762
Closed -$1.75M
MTG icon
79
MGIC Investment
MTG
$6.47B
– –
-4,104,737
Closed -$38M
PFE icon
80
CALL
Pfizer
PFE
$143B
– –
-2,326,600
Closed -$265K
PFE icon
81
Pfizer
PFE
$143B
– –
-5,564,481
Closed -$166M
PTCT icon
82
CALL
PTC Therapeutics
PTCT
$6.18B
– –
-428,200
Closed -$1.31M
ROK icon
83
CALL
Rockwell Automation
ROK
$51.1B
– –
-388,600
Closed -$87K
TDOC icon
84
Teladoc Health
TDOC
$1.66B
– –
-13,670
Closed -$305K
TEVA icon
85
CALL
Teva Pharmaceuticals
TEVA
$40.4B
– –
-2,713,000
Closed -$1.01M
RDUS
86
DELISTED
Radius Health, Inc.
RDUS
– –
-577,034
Closed -$40M
AIMT
87
DELISTED
Aimmune Therapeutics
AIMT
– –
-996,112
Closed -$25.2M
AGN
88
CALL
DELISTED
Allergan plc
AGN
– –
-314,700
Closed -$2.52M
FOMX
89
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-506,920
Closed -$3.72M
KERX
90
DELISTED
Keryx Biopharmaceuticals Inc
KERX
– –
-97,687
Closed -$344K
BRCM
91
DELISTED
BROADCOM CORP CL-A
BRCM
– –
-1,271,730
Closed -$65.4M
THOR
92
DELISTED
THORATEC CORPORATION
THOR
– –
-432,577
Closed -$27.4M
KYTH
93
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
– –
-20,589
Closed -$1.54M
BCR
94
DELISTED
CR Bard Inc.
BCR
– –
-75,570
Closed -$14.1M
LNKD
95
DELISTED
LinkedIn Corporation
LNKD
– –
-151,848
Closed -$28.9M
1 2 3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
AC
AWM Capital Phoenix, Arizona $1.1B AUM 15.03% 1-Year Est. Return

PFM Health Sciences's Q4 2015 Portfolio in Review

As of Q4 2015, PFM Health Sciences held 97 positions worth $3.29B, down 7.4% from $3.55B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

PFM Health Sciences withdrew a net $511M in Q4 2015, closing 30 positions and reducing 21 holdings. Its most notable exit was Pfizer, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 59% a quarter earlier, followed by Technology and Industrials.

Against the trend, PFM Health Sciences opened a new position in Alphabet (Google) Class A worth $107M.

  • PFM Health Sciences's largest Q4 2015 buy was Alphabet (Google) Class A: 2,750,720 shares worth $107M.
  • PFM Health Sciences added most to Bristol-Myers Squibb in Q4 2015, an estimated $51.4M increase.
  • PFM Health Sciences's biggest Q4 2015 reduction was UnitedHealth, cutting an estimated $151M.
  • PFM Health Sciences fully exited Pfizer in Q4 2015, selling an estimated $166M.
  • PFM Health Sciences's ten largest holdings make up 40% of its $3.29B portfolio in Q4 2015.
  • PFM Health Sciences opened 23 new positions and closed 30 in Q4 2015.
  • PFM Health Sciences's portfolio value fell 7.4% quarter-over-quarter to $3.29B.

Based on PFM Health Sciences's 13F filing for Q4 2015, filed 16 Feb 2016.